(Q50644770)

17 March 2018

title

Age-matched comparison of recombinant and urinary HCG for final follicular maturation (English)

1 reference

17 March 2018

author name string

Meike L Uhler

1

1 reference

17 March 2018

Angeline N Beltsos

2

1 reference

17 March 2018

H Edward Grotjan

3

1 reference

17 March 2018

Kevin J Lederer

4

1 reference

17 March 2018

Aaron S Lifchez

5

1 reference

17 March 2018

publication date

1 September 2006

1 reference

17 March 2018

Reproductive BioMedicine Online

published in

1 reference

17 March 2018

volume

13

1 reference

17 March 2018

issue

3

1 reference

17 March 2018

page(s)

315-320

1 reference

17 March 2018

A prospective, randomized and blinded comparison between 10,000 IU urinary and 250 microg recombinant human chorionic gonadotropin for oocyte maturation in in vitro fertilization cycles

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Cochrane Database of Systematic Reviews

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertil

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Recombinant LH in ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-em

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Comparison of recombinant hCG and urinary hCG.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

LH improves early follicular recruitment in women over 38 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Comparative use of urinary and recombinant human chorionic gonadotropins in women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Clinical assessment of human gonadotrophins produced by recombinant DNA technology

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Use of recombinant human chorionic gonadotropin in ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961433-2

7 January 2021

10.1016/S1472-6483(10)61433-2

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018